Cabozantinib

Female Reproductive Organ Cancer

M.D. Anderson Cancer CenterSmall moleculePhase 1

—

Rating in progress

Cabozantinib in Female Reproductive Organ Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active